Dabigatran etexilate mesylate (
Pradaxa®) is a prescription medication approved to reduce the risk of
stroke and blood clots in people with
atrial fibrillation, a certain type of irregular heart rhythm (arrhythmia).
Approved by the United States Food and Drug Administration (FDA) in October 2010, dabigatran is a long-awaited "blood thinner" that is easier to dose, requires less monitoring, and is more effective, compared to
warfarin (
Coumadin®,
Jantoven®).
Just like any medicine, dabigatran can cause side effects. Although some side effects of this medication are merely bothersome, some can be very dangerous. Most serious side effects are related to the increased risk of bleeding.
In clinical studies, some of the most common side effects reported in people taking this medication (plus aspirin) included but were not limited to:
- Bleeding
- Gastrointestinal side effects, such as abdominal (stomach) pain or indigestion.
(Click Side Effects of Dabigatran to learn more, including potentially serious side effects that you should report immediately to your healthcare provider.)